Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Patrick K. Reville"'
Autor:
Lianchun Xiao, Sanam Loghavi, Marina Konopleva, Tapan M. Kadia, Patrick K. Reville, Gautam Borthakur, Gheath Alatrash, Elias Jabbour, Naveen Pemmaraju, Naval Daver, Courtney D. DiNardo, Yesid Alvarado, Caitlin R. Rausch, Hagop M. Kantarjian, Maro Ohanian, Jorge E. Cortes, Farhad Ravandi
Publikováno v:
Blood Cancer Journal
Blood Cancer Journal, Vol 11, Iss 3, Pp 1-5 (2021)
Blood Cancer Journal, Vol 11, Iss 3, Pp 1-5 (2021)
Autor:
Patrick K. Reville, Tapan M. Kadia
Publikováno v:
Frontiers in Oncology, Vol 10 (2021)
Frontiers in Oncology
Frontiers in Oncology
Recent advances in therapeutics coupled with steady improvements in supportive care for patients with acute myeloid leukemia (AML) have led to improved outcomes. Despite these advances, even in patients that achieve a complete remission with initial
Autor:
Elisabeth Paietta, Fangxin Hong, Brad S. Kahl, Kyung Mann Kim, Vaishalee P. Kenkre, Bartosz Grzywacz, Erik A. Ranheim, Patrick K. Reville, Lakeesha Carmichael, Eneida A. Mendonça, Amy K. Erbe, Wei Wang, Paul M. Sondel, Sandra J. Horning, Anna Hoefges, Yiqiang Song, Songwon Seo, Jeffrey S. Miller, Randy D. Gascoyne, Jacquelyn A. Hank
Publikováno v:
Journal for Immunotherapy of Cancer
Journal for ImmunoTherapy of Cancer, Vol 7, Iss 1, Pp 1-12 (2019)
Journal for ImmunoTherapy of Cancer, Vol 7, Iss 1, Pp 1-12 (2019)
Background The ECOG-ACRIN Cancer Research Group evaluated rituximab treatment schedules for patients with newly-diagnosed low-tumor-burden follicular-lymphoma (FL). All patients received 4-weekly rituximab treatments as induction therapy. Clinically-